Abstract
During the last few years multiple studies have demonstrated that aspirin administration is effective in reducing the risk of coronary artery disease and ischemic cerebrovascular disease in men and women respectively. The benefit of receiving low-dose aspirin (75-160 mg/d) clearly overcomes the risk of hemorrhagic complications in subjects with a coronary heart disease risk of >=1% per year (>=10% in 10 years). Despite this evidence, the use of low-dose aspirin as a primary prevention strategy is not fully established yet. The application of the current recommendations of aspirin use in primary prevention could be beneficial in the Colombian population, especially because evidence shows a greater susceptibility to present high levels of chronic low-degree inflammation associated to a greater cardiovascular risk in our population. However, further studies are needed to confirm this hypothesis.
| Translated title of the contribution | Uso de aspirina en la prevención de enfermedades cardiovasculares |
|---|---|
| Original language | English |
| Pages (from-to) | 223-230 |
| Number of pages | 8 |
| Journal | Revista Colombiana de Cardiologia |
| Volume | 15 |
| Issue number | 5 |
| State | Published - Sep 2008 |
| Externally published | Yes |
Keywords
- Aspirin
- Coronary artery disease
- Inflammation
- Prevention
- Risk-benefit
